Singh et al., 2008 - Google Patents
Recovery in advanced clinical cases of Johne's disease in naturally infected goats using a highly efficacious indigenous vaccine made from novel Indian strain of …Singh et al., 2008
- Document ID
- 870943488589482477
- Author
- Singh S
- Singh P
- Singh A
- Sohal J
- Publication year
External Links
Snippet
Seventy-one ready to cull (weak/diarrheic) naturally infected (positive in ELISA and fecal culture) farm goats had clinical to advanced clinical signs of JD. The goats were divided randomly into 3 groups;'Bison'(Indigenous vaccine), Gudair (Commercial vaccine) and …
- 241000283707 Capra 0 title abstract description 70
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rosseels et al. | Vaccination against paratuberculosis | |
| Buddle et al. | Immunological responses and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG | |
| US7758875B2 (en) | Vaccine | |
| Körmendy | The effect of vaccination on the prevalence of paratuberculosis in large dairy herds | |
| Singh et al. | Comparative efficacy of an indigenous ‘inactivated vaccine’using highly pathogenic field strain of Mycobacterium avium subspecies paratuberculosis ‘Bison type’with a commercial vaccine for the control of Capri-paratuberculosis in India | |
| AU2002326240A1 (en) | Vaccine | |
| Vordermeier et al. | Toward the development of diagnostic assays to discriminate between Mycobacterium bovis infection and bacille Calmette-Guerin vaccination in cattle | |
| Hines II et al. | Efficacy of spheroplastic and cell-wall competent vaccines for Mycobacterium avium subsp. paratuberculosis in experimentally-challenged baby goats | |
| UA121097C2 (en) | Immunogenic composition comprising mycoplasma antigens | |
| Bactol et al. | Immune response of tilapia (Oreochromis niloticus) after vaccination with autoclave-killed, heat-killed, and formalin-killed whole cell Aeromonas hydrophila vaccines as possible serotype-independent vaccines. | |
| Singh et al. | Therapeutic Effects of a New “Indigenous Vaccine” Developed Using Novel Native “Indian Bison Type” Genotype of Mycobacterium avium Subspecies paratuberculosis for the Control of Clinical Johne′ s Disease in Naturally Infected Goatherds in India | |
| Singh et al. | Recovery in advanced clinical cases of Johne's disease in naturally infected goats using a highly efficacious indigenous vaccine made from novel Indian strain of Mycobacterium avium subspecies paratuberculosis' Bison type'. | |
| EP1855716B1 (en) | Compositions for eliciting an immune response against mycobacterium avium subspecies paratuberculosis | |
| Seo et al. | Comparison of cell-mediated immunity induced by three commercial single-dose Mycoplasma hyopneumoniae bacterins in pigs | |
| Al-Samarrae | Evaluation of Proteus vulgarisfimbriae antigen by delayed type hypersensitivity (DTH)-skin test in rabbits | |
| AB et al. | Trial of inactivated bluetongue vaccine in Bharat-Merino sheep | |
| Velasquez et al. | Serology and DNA-based detection and serotyping of Actinobacillus pleuropneumoniae Pohl from backyard pigs in selected provinces of Luzon, Philippines | |
| Yirsaw | CAPRINE γδ T CELL BIOLOGY | |
| CN1843506A (en) | A kind of Mycobacterium tuberculosis vaccine kit medicine | |
| Altun et al. | Immunogenic and antigenic profiles of nine Lactococcus garvieae strains from different rainbow trout farms | |
| Liu et al. | Evaluation of vaccine candidates against Rhodococcus equi in BALB/c mice infection model: cellular and humoral immune responses | |
| Fernández Fernández et al. | Effects of paratuberculosis vaccination at different ages in a dairy goat Herd: A 2-year follow-up | |
| Buddle et al. | Experimental infection models of tuberculosis in domestic and wild animals | |
| El-Hady et al. | Endemic situation of Brucellosis in dairy farms after RB51 vaccination | |
| Geijo et al. | Paratuberculosis vaccination response in cattle, sheep and goats. |